Amy Schneider
- Infectious Diseases top 2%
- Molecular Medicine top 1%
- Molecular Biology
- Epidemiology top 10%
- Clinical Biochemistry top 1%
- Co-authors
- Scott K. FridkinJean B. PatelAlex KallenDawn SievertArjun SrinivasanJonathan R. EdwardsBrandi LimbagoPhilip Ricks
- Topics
- Monoclonal and Polyclonal Antibodies Research (11 papers)Economic and Financial Impacts of Cancer (4 papers)Ovarian cancer diagnosis and treatment (3 papers)
- Partner nations
- United StatesSlovakiaUnited Kingdom
In The Last Decade
Amy Schneider
27 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 122
- Infectious Diseases 635
- Molecular Medicine 471
- Molecular Biology 467
- Epidemiology 422
- Clinical Biochemistry 313
Countries citing papers authored by Amy Schneider
This map shows the geographic impact of Amy Schneider's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Schneider with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Schneider more than expected).
Fields of papers citing papers by Amy Schneider
This network shows the impact of papers produced by Amy Schneider. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Schneider. The network helps show where Amy Schneider may publish in the future.
Co-authorship network of co-authors of Amy Schneider
This figure shows the co-authorship network connecting the top 25 collaborators of Amy Schneider. A scholar is included among the top collaborators of Amy Schneider based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Schneider. Amy Schneider is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 13 | |
| 3 | 1 | |
| 4 | 2 | |
| 5 | 4 | |
| 6 | 9 | |
| 7 | 36 | |
| 8 | 64 | |
| 9 | 16 | |
| 10 | 21 | |
| 11 | 9 | |
| 12 | 3 | |
| 13 | 8 | |
| 14 | 2 | |
| 15 | 5 | |
| 16 | Antimicrobial-Resistant Pathogens Associated with Healthcare-Associated Infections Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010breakdown → | 1229 |
| 17 | 48 | |
| 18 | 7 | |
| 19 | 124 | |
| 20 | 15 |
About Amy Schneider
Amy Schneider is a scholar working on General Dentistry, Applied Microbiology and Biotechnology and Radiology, Nuclear Medicine and Imaging, having authored 29 papers that have together received 1.8k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (11 papers), Economic and Financial Impacts of Cancer (4 papers) and Ovarian cancer diagnosis and treatment (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (215 citations), Molecular Medicine (471 citations) and Clinical Biochemistry (313 citations). Amy Schneider has collaborated with scholars based in United States, Slovakia and United Kingdom. Frequent co-authors include Scott K. Fridkin, Jean B. Patel, Alex Kallen, Dawn Sievert, Arjun Srinivasan, Jonathan R. Edwards, Brandi Limbago, Philip Ricks, Joseph M. Patti and Meina Liang. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.